[1]
Plaitakis, A.; Duvoisin, R.C. Homer’s moly identified as Galanthus nivalis L.: physiologic antidote to stramonium poisoning. Clin. Neuropharmacol., 1983, 6(1), 1-5.
[2]
Hsieh, L.E.; Lin, C.N.; Su, B.L.; Jan, T.R.; Chen, C.M.; Wang, C.H.; Lin, D.S.; Lin, C.T.; Chueh, L.L. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antiviral Res., 2010, 88(1), 25-30.
[3]
Heinrich, M. Galanthamine from Galanthus and other Amaryllidaceae-chemistry and biology based on traditional use. Alkaloids Chem. Biol., 2010, 68, 157-165.
[4]
Tsvetkova, D.; Obreshkova, D.; Zheleva-Dimitrova, D.; Saso, L. Antioxidant activity of galantamine and some of its derivatives. Curr. Med. Chem., 2013, 20(36), 4595-4608.
[5]
Loy, C.; Schneider, L. Galantamine for Alzheimer’s disease and mild cognitive impairment. Cochrane Database Syst. Rev., 2006, 1.
[6]
Song, J.; Ahn, I.S.; Kang, H.S.; Myung, W.; Lee, Y.; Woo, S.Y.; Ku, H.M.; Hwang, T.Y.; Carroll, B.J.; Kim, D.K. Cognitive subdomain responses to galantamine in Alzheimer’s disease. J. Nerv. Ment. Dis., 2014, 202(3), 253-259.
[7]
Richarz, U.; Gaudig, M.; Rettig, K.; Schauble, B. Galantamine treatment in outpatients with mild Alzheimer’s disease. Acta Neurol. Scand., 2014, 129(6), 382-392.
[8]
Ghaleiha, A.; Ghyasvand, M.; Mohammadi, M.R.; Farokhnia, M.; Yadegari, N.; Tabrizi, M.; Hajiaghaee, R.; Yekehtaz, H.; Akhondzadeh, S. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. J. Psychopharmacol. (Oxford, England), 2014, 28(7), 677-685.
[9]
Koseki, T.; Mouri, A.; Suzuki, S.; Nakajima, A.; Mamiya, T.; Yan, Y.; Nabeshima, T. Galantamine attenuates reinstatement of cue-induced methamphetamine-seeking behavior in mice. Addict. Biol., 2014, 19(1), 1-4.
[10]
Izzo, A.A.; Hoon‐Kim, S.; Radhakrishnan, R.; Williamson, E.M. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother. Res., 2016, 30(5), 691-700.
[11]
Poulsen, M.; Kroghsbo, S.; Schroder, M.; Wilcks, A.; Jacobsen, H.; Miller, A.; Frenzel, T.; Danier, J.; Rychlik, M.; Shu, Q.; Emami, K.; Sudhakar, D.; Gatehouse, A.; Engel, K.H.; Knudsen, I. A 90-day safety study in Wistar rats fed genetically modified rice expressing snowdrop lectin Galanthus nivalis (GNA). Food Chem. Toxicol., 2007, 45(3), 350-363.
[12]
Ewen, S.W.; Pusztai, A. Effect of diets containing genetically modified potatoes expressing Galanthus nivalis lectin on rat small intestine. Lancet, 1999, 354(9187), 1353-1354.
[13]
Combs, H.; Markman, J. Anxiety disorders in primary care. Med. Clin. North Am., 2014, 98(5), 1007-1023.
[14]
Wazea, S.A.; Wadie, W.; Bahgat, A.K.; El-Abhar, H.S. Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-kappaB/HMGB1/RAGE and p-AKT/Bcl-2 pathways. Sci. Rep., 2018, 8(1), 5110.
[15]
Picciotto, M.R.; Lewis, A.S.; van Schalkwyk, G.I.; Mineur, Y.S. Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states. Neuropharmacology, 2015. 96(Pt B), 235-243.
[16]
Stanford, S.C. Open fields (unlike wheels) can be any shape but still miss the target. J. Psychopharmacol., 2007, 21(2), 144.
[17]
Stanford, S.C. The Open Field Test: reinventing the wheel. J. Psychopharmacol., 2007, 21(2), 134-135.
[18]
Walsh, R.N.; Cummins, R.A. The Open-Field Test: A critical review. Psychol. Bull., 1976, 83(3), 482-504.
[19]
Makowska, I.J.; Weary, D.M. The importance of burrowing, climbing and standing upright for laboratory rats. R. Soc. Open Sci., 2016, 3(6), 160136.
[20]
Makowska, I.J.; Weary, D.M. Differences in Anticipatory behaviour between rats (Rattus norvegicus) housed in standard versus semi-naturalistic laboratory environments. PLoS One, 2016, 11(1), e0147595.
[21]
Bokov, D.O.; Samylina, I.A. Comparison of the chemical compositions of Galanthus woronowii losinsk. and Galanthus nivalis l. Homeopathic mother tinctures by gas chromatography with mass-selective detection. Pharm. Chem. J., 2017, 50(10), 659-667.
[22]
Sarikaya, B.B.; Somer, N.U.; Kaya, G.I.; Onur, M.A.; Bastida, J.; Berkov, S. GC-MS investigation and acetylcholinesterase inhibitory activity of Galanthus rizehensis. Zeitschrift fur Naturforschung. C. J. Biosci., 2013, 68(3-4), 118-124.
[23]
Fernandes, S.S.; Koth, A.P.; Parfitt, G.M.; Cordeiro, M.F.; Peixoto, C.S.; Soubhia, A.; Moreira, F.P.; Wiener, C.D.; Oses, J.P.; Kaszubowski, E.; Barros, D.M. Enhanced cholinergic-tone during the stress induce a depressive-like state in mice. Behav. Brain Res., 2018, 347, 17-25.
[24]
Kroes, R.A.; Burgdorf, J.; Otto, N.J.; Panksepp, J.; Moskal, J.R. Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray. Behav. Brain Res., 2007, 182(2), 290-300.
[25]
Leng, A.; Feldon, J.; Ferger, B. Long-term social isolation and medial prefrontal cortex: Dopaminergic and cholinergic neurotransmission. Pharmacol. Biochem. Behav., 2004, 77(2), 371-379.
[26]
Fang, L.; Fang, X.; Gou, S.; Lupp, A.; Lenhardt, I.; Sun, Y.; Huang, Z.; Chen, Y.; Zhang, Y.; Fleck, C. Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents. Eur. J. Med. Chem., 2014, 76, 376-386.